FDA approves much-debated Alzheimer’s drug panned by experts

WASHINGTON, United States (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated… Read more »